Is this email not displaying correctly? View it in your browser.
 
Newswise - News for Journalists
Newswise Special Wire
Tuesday, September 17, 2019

Public edition | newswise.com

Newswise Cancer Research Wire for 17-Sep-2019
 

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.


Cancer Research


Breast Cancer Screening Found Effective in Men at High Risk for the Disease

Men at high risk of developing breast cancer may benefit from mammography, or breast X-ray, screening for the disease, a new study shows.

– NYU Langone Health

Radiology

Embargo expired on 17-Sep-2019 at 10:00 ET


Study in JNCCN Supports Idea that Higher Patient Volumes are Associated with Longer Survival in Multiple Myeloma

New research in the September 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that providers with more experience treating people with multiple myeloma have better outcomes than those with more limited experience.

– National Comprehensive Cancer Network® (NCCN®)

Embargo expired on 17-Sep-2019 at 09:00 ET


Most American adults do not know that HPV causes oral, anal, and penile cancers

More than 70% of U.S. adults are unaware that human papillomavirus (HPV) causes anal, penile, and oral cancers, according to an analysis led by researchers at The University of Texas Health Science Center at Houston (UTHealth) published in the curren...

– University of Texas Health Science Center at Houston

JAMA Pediatrics

Embargo expired on 16-Sep-2019 at 11:00 ET


Two Studies Show Promise, Safety of Proton Therapy in the Brain in Children with Cancer

From improving outcomes in children with brain cancer to lowering the risk of damage to the brainstem in children with central nervous system tumors, a pair of new studies published today add to the growing body of research showing the potential bene...

– Perelman School of Medicine at the University of Pennsylvania

Pediatric Blood and Cancer; Acta Oncologica

Embargo expired on 12-Sep-2019 at 08:00 ET


First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles

A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.

– Children's Hospital Los Angeles

Journal of Clinical Oncology, Sep-2019; U10CA180886; U10CA180899; U10CA098543; U10CA098413


Label-free microscope detects ovarian metastatic cancer

Cancer in the ovaries often metastasizes to the surrounding tissues, but is too small to be detected. Now a label-free microscopy technique is able to identify these regions with great accuracy, enabling early removal of these microscopic malignancie...

– National Institute of Biomedical Imaging and Bioengineering

Biomedical Optics Express, Sept-2019; EB023498


Meatballs might wreck the anti-cancer perks of tomato sauce

Some of the anti-cancer benefits of tomatoes, specifically those from a compound called lycopene, could disappear when they’re eaten with iron-rich foods, according to a new study from The Ohio State University.

– Ohio State University


Just bad luck? Cancer patients nominate ‘fate’ as third most likely cause

What role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia and 125,000 people in Vietnam?

– University of South Australia

Cancer Control


Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses

– Weizmann Institute of Science

Cell, Sept-2019


Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings. Now, researchers at Johns Hopkins Medicine hav...

– Johns Hopkins Medicine

Nature Communications; W81XWH-15-1-0301, W81XWH-14-1-0239, 1U44AA026111-01, 2016-MII-4352, NRF-2013K1A1A2A02050115, NRF-2016R1A2B4006914, NRF-2018R1A


Predictors of Response to Guadecitabine Found in Relapsed/Refractory AML Patients

Patients with acute myeloid leukemia (AML), a leukemia which arises from bone marrow tissue, often see remission following their initial treatment, but for patients whose cancer returns, there are few options. One such option is guadecitabine, a nove...

– Coriell Institute for Medical Research

Clinical Epigenetics, July 2019; R01CA158112 ; P50CA100632


Can scientists predict which cancer markers are likely to trigger an immune response?

In a study published in the journal Cancer Immunology Research, University of North Carolina Lineberger Comprehensive Cancer Center researchers reported on the discovery of a method for predicting whether abnormal proteins produced by cancer cells co...

– University of North Carolina Health Care System

Cancer Immunology Research, September 2019


Markey Researchers Discover Role of Nuclear Glycogen in Non-small Cell Lung Cancers

Researchers at the University of Kentucky Markey Cancer Center have made a breakthrough discovery that solves a mystery long forgotten by science and have identified a potentially novel avenue in pre-clinical models to treat non-small cell lung cance...

– University of Kentucky

Cell Metabolism


The Genetics of Cancer

A research team has identified a new circular RNA (ribonucleic acid) that increases tumor activity in soft tissue and connective tissue tumors. The discovery may help improve how cancer is identified and treated.

– University of Delaware

Cell Research


Trio of Studies Show that Gene Mutation, Tissue Location and Signaling Networks Drive Cancer Incidence and Severity

Mutated KRAS genes are commonly found in several cancers and not all KRAS mutations in the same organ tissue cause the same disease severity, according to three new studies from researchers at the Cancer Center at Beth Israel Deaconess Medical Center...

– Beth Israel Deaconess Medical Center

Cancer Discovery ; Cell Reports; Cell Systems; R01CA178017; R01CA195744; U01CA215798; R01CA173085; P30CA082103; K01DK098285; MCB-1244203...


Meet the molecule that helps stressed cells decide between life and death

St. Jude Children’s Research Hospital scientists have identified a molecule that plays a pivotal role in determining the fate of cells under stress, much like a Roman emperor deciding the fate of gladiators in the coliseum.

– St. Jude Children's Research Hospital

Nature, Sept-2011; AI101935; AI124346; AR056296; CA163507; CA02176535; CA96832


Existing drug could treat aggressive brain cancer

A research team from the University of Georgia’s Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer.

– University of Georgia

FASEB Journal


Cancer Predisposition Clinic Aims To Change Trajectory Of Genetically Based Cancer

Children’s of Alabama’s Cancer Predisposition Clinic physicians develop personalized screening for children who have inherited cancer predisposition syndromes with hopes that early detection will lead to improved outcomes.

– Children's of Alabama


Staying Home for Treatment

UNM Cancer Center’s Bone Marrow Transplant program is the first in the state to achieve FACT accreditation, enabling many more New Mexicans with blood disorders to stay home

– University of New Mexico Comprehensive Cancer Center


Cancer Experts and Features


Prostate Cancer Patients Can Pursue Healthy Sex Lives After Surgery

Prostate cancer doesn't have the spell the end of a healthy sex life. Survivorship programs promote sexual recovery after cancer treatment.

– Michigan Medicine - University of Michigan


New Federal Guidelines for BRCA Testing: Should You Be Screened?

More women than ever are being encouraged to undergo screening for BRCA gene mutations, based on newly announced U.S. Preventive Services Task Force recommendations. The task force recommends that:

– Cedars-Sinai


Pediatric Hematology / Oncology Nurse Taking on Life after Cancer

September 2019 marks two years since Courtney Alvis was hired as a pediatric hematology/oncology nurse at Children’s of Alabama, where in 2010 she was diagnosed with acute T-cell leukemia at age 16.

– Children's of Alabama


Recognizing signs and symptoms of sepsis can save lives

Sepsis kills more people every year than heart attacks, breast cancer and other diseases. However, a survey found that most Americans have no idea what it is. Most think it's a hospital-borne illness, but, in fact, 80% of people bring sepsis into the...

– Houston Methodist


Northwestern Medicine physicians, staff prepare to present at ASTRO 2019

Radiation oncologists and team members from the Northwestern Medicine Chicago Proton Center and Robert H. Lurie Cancer Center of Northwestern University at Northwestern Memorial Hospital will present research at the annual meeting for the American So...

– Northwestern Medicine


ASTRO comments to the Centers for Medicare and Medicaid Services regarding their proposed radiation oncology alternative payment model

In response to the Centers for Medicare and Medicaid Services' (CMS) request for comment on their proposed advanced alternative payment model (APM) for radiation oncology, the American Society for Radiation Oncology (ASTRO) submitted comments and iss...

– American Society for Radiation Oncology (ASTRO)


Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

The National Comprehensive Cancer Network® (NCCN®) hosted a policy summit at the National Press Club in Washington, DC, addressing how to define, measure, and apply quality in cancer care.

– National Comprehensive Cancer Network® (NCCN®)


Cancer Announcements


Dana-Farber Cancer Institute receives $5 million gift to create the Edward P. Evans Center for Myelodysplastic Syndromes

A $5 million gift from the Edward P. Evans Foundation will create the Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Dana-Farber Cancer Institute.

– Dana-Farber Cancer Institute

Embargo expired on 17-Sep-2019 at 08:00 ET


American College of Radiology Acquires and Expands CT Colonography Locator Tool

The American College of Radiology (ACR) has acquired the My CT Colonography center online locator, a patient-friendly online tool to find a computed tomography (CT) colonography screening center near you. The ACR will now work with stakeholders to ex...

– American College of Radiology (ACR)


Racquel (Kelly) Kohler Joins the Rutgers School of Public Health

The Rutgers School of Public Health is excited to announce that Racquel (Kelly) Kohler, PhD, has joined the department of health behavior, society, and policy, as an instructor, and the Center for Cancer Health Equity at Rutgers Cancer Institute of N...

– Rutgers School of Public Health


Penn’s Angela DeMichele, MD, MSCE, Part of Team Awarded Stand Up 2 Cancer Grant

A new $3 million grant to support a clinical trial evaluating a combination therapy to prevent triple-negative breast cancer from recurring, which will be led in the clinic by Angela DeMichele, MD, MSCE, the Alan and Jill Miller Professor in Breast C...

– Perelman School of Medicine at the University of Pennsylvania


$1.25 Million Gift to Endow Chair at Jersey Shore University Medical Center

The Hackensack Meridian Health Jersey Shore University Medical Center Foundation is pleased to announce a gift of $1.25 million from Charles Adell to create The Charles & Jackie Adell Endowed Chair in Surgical Oncology at Jersey Shore University Medi...

– Hackensack Meridian Health


Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

The Icahn School of Medicine at Mount Sinai has been awarded nearly $1.7 million in grant funding from the U.S. Department of Defense to study how bladder cancer affects certain types of white blood cells called “natural killer” cells, or NK cel...

– Mount Sinai Health System


Penn Announces Completion of Exclusive R&D Alliance With Novartis and Development of New Focused Relationship

The University of Pennsylvania and Novartis have concluded their seven-year research and development alliance, which resulted in the world’s first approved gene therapy for cancer. They will continue to work together on a more narrow CAR T cell the...

– Perelman School of Medicine at the University of Pennsylvania


Cowboys Saddle Up to Support Cancer Research

For 37 years, Cowboys for Cancer Research has been fundraising to support the fight against cancer. The non-profit group raises funds for research through donations, endowment funds and events like the upcoming Dinner-Dance-Silent Auction.

– University of New Mexico Comprehensive Cancer Center


Rutgers Experts To Speak on the Continued Health Risks Faced by First Responders Ahead of 9/11 Anniversary

– Rutgers University-New Brunswick

Tips

CUSTOMIZE YOUR FAVORITES WITH "MY READING LIST"

MY CHANNELS  |  SAVED ARTICLES  |  MY SOURCES  |  MY EXPERTS

MORE CHANNELS:
JOURNAL NEWS   |  TRENDS AND TOP STORIES   |  LOCAL NEWS  |  MEDICAL and SCIENTIFIC MEETINGS

Support
 Subscribe/Unsubscribe
 Edit My Preferences
 Comments/Suggestions
 Contact Us
 
Services
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 University of Georgia

 University of Kentucky

 Northwestern Medicine

 University of California, Los Angeles (UCLA), Health Sciences

 Michigan Medicine - University of Michigan


Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us